精浆外泌体microRNA是无精子症病因标志物,可预测睾丸组织内是否存在精子
前瞻性病例对照研究比较精浆外泌体microRNA谱,纳入9例正常精液生育对照、14例生精衰竭性无精子症和13例梗阻性无精子症患者,另含3例严重少精子症患者。研究发现miR-31-5p对无精子症病因预测的敏感性和特异性均>90%,联合血FSH后效能更佳;包含miR-539-5p和miR-941的模型可用于预测严重生精障碍者是否存在残余生精。
要点
- 精浆外泌体miR-31-5p预测无精子症病因的敏感性和特异性均>90%。
- 联合血FSH值分析后,miR-31-5p预测无精子症病因的效能更佳。
- 包含miR-539-5p和miR-941的模型可用于预测严重生精障碍者的残余生精。
核心结论
- 精浆小细胞外囊泡中的多种microRNA可作为敏感且特异的生物标志物,用于筛选有实际机会通过睾丸活检获得精子的无精子症个体。
- 包含miR-539-5p和miR-941表达值的模型可用于预测严重生精障碍个体是否存在残余生精,具有诊断准确性。
- 研究发现有助于寻找可用于预测无精子症个体睾丸内是否存在精子的遗传标志物。
研究设计与样本
- 前瞻性病例对照研究,比较精浆外泌体microRNA含量。
- 对照组为9例正常精液生育个体,病例组为14例生精衰竭性无精子症和13例梗阻性无精子症且生精保留个体。
- 另纳入3例严重少精子症个体(<5 × 10^6 精子/ml)。
- 使用microRNA定量PCR panel进行差异高通量microRNA谱分析。
主要发现
- microRNA谱分析阶段共纳入623个microRNA,其中397个(63.7%)在所有组样本中一致检出并进行统计分析,揭示不育患者存在microRNA表达模式改变。
- 在验证阶段,精浆外泌体miR-31-5p作为预测无精子症病因的生物标志物检测,敏感性和特异性均>90%。
- 将血FSH值纳入分析后,该预测检测的效能更佳。
- 包含miR-539-5p和miR-941表达值的模型可用于预测严重生精障碍个体是否存在残余生精,具有诊断准确性。
局限性
- 需要进一步研究,纳入独立第二人群和更大样本量,以确认本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are exosomal microRNAs (miRNAs) in seminal plasma (SP) useful as markers of the origin of azoospermia and the presence of sperm in the testis? SUMMARY ANSWER: Our study demonstrated the potential of several miRNAs contained in small extracellular vesicles (sEVs) of seminal fluid as sensitive and specific biomarkers for selecting those azoospermic individuals with real chances of obtaining spermatozoa from the testicular biopsy. WHAT IS KNOWN ALREADY: There are no precise non-invasive diagnostic methods for classifying the origin of the sperm defects in semen and the spermatogenic reserve of the testis in those infertile men with a total absence of sperm in the ejaculate (azoospermia). The diagnosis of such individuals is often based on the practice of biopsies. In this context it is reasonable to study the presence of organ-specific markers in human semen that contains fluid from the testis and the male reproductive glands, which could help in the diagnosis and prognosis of male infertility. Additionally, seminal fluid contains high concentrations of sEVs that are morphologically and molecularly consistent with exosomes, which originate from multiple cellular sources in the male reproductive tract. STUDY DESIGN, SIZE, DURATION: A case and control prospective study was performed. This study compares the miRNA content of exosomes in semen samples obtained from nine normozoospermic fertile individuals (control group), 14 infertile men diagnosed with azoospermia due to spermatogenic failure, and 13 individuals with obstructive azoospermia and conserved spermatogenesis. Additionally, three severe oligozoospermic individuals (<5 × 106 sperm/ml) were included in the study. PARTICIPANTS/MATERIALS, SETTING, METHODS: A differential high-throughput miRNA profiling analysis using miRNA quantitative PCR panels was performed in SP exosomes from azoospermic patients and fertile individuals. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 623 miRNAs were included in the miRNA profiling stage of the study. A total of 397 miRNAs (63.7%) were consistently detected in samples from all groups and statistically analysed, which revealed altered patterns of miRNA expression in infertile patients. We focused on the miRNAs that were differentially expressed between azoospermia as a result of an obstruction in the genital tract (i.e. having conserved spermatogenesis) and azoospermia caused by spermatogenic failure, and described, in a miRNA validation stage of the study, the expression values of one miRNA (miR-31-5p) in exosomes from semen as a predictive biomarker test for the origin of azoospermia with high sensitivity and specificity (>90%). The efficacy of the predictive test was even better when the blood FSH values were included in the analysis. Furthermore a model that included miR-539-5p and miR-941 expression values is also described as being useful for predicting the presence of residual spermatogenesis in individuals with severe spermatogenic disorders with diagnostic accuracy. LIMITATIONS, REASONS FOR CAUTION: Further studies, with an independent second population involving a larger number of samples, are needed to confirm our findings. WIDER IMPLICATIONS OF THE FINDINGS: Our findings contribute to the search for the most valuable genetic markers that are potentially useful as tools for predicting the presence of testicular sperm in azoospermic individuals. STUDY FUNDING/COMPETING INTEREST(S): This work was financially supported by grants from the Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa" (FIS/FEDER) [Grant number PI15/00153], the Generalitat de Catalunya [Grant number 2014SGR5412]. S.L. is sponsored by the Researchers Stabilization Program (ISCIII/Generalitat de Catalunya) from the Spanish National Health System [CES09/020].
引用
- Barceló M, Mata A, Bassas L, et al. Exosomal microRNAs in seminal plasma are markers of the origin of azoospermia and can predict the presence of sperm in testicular tissue. Hum Reprod. 2018. PMID: 29635626. doi:10.1093/humrep/dey072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。